検索結果 - Ryu Kasai

  • 検索結果 1 - 2 結果 / 2
結果の絞り込み
  1. 1
    A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A

    A Pharmacometric Approach to Substitute for a Conventional Dose-Finding Study in Rare Diseases: Example of Phase III Dose Selection for Emicizumab in Hemophilia A 著者: Koichiro Yoneyama, Christophe Schmitt, Naoki Kotani, Gallia G. Levy, Ryu Kasai, Satofumi Iida, Midori Shima, Takehiko Kawanishi

    出版事項 2017
    全文の入手 全文の入手
    Artigo
    お気に入りに追加
    保存先:
  2. 2
    Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors

    Long-term safety and efficacy of emicizumab in a phase 1/2 study in patients with hemophilia A with or without inhibitors 著者: Midori Shima, Hideji Hanabusa, Masashi Taki, Tadashi Matsushita, Tetsuji Sato, Katsuyuki Fukutake, Ryu Kasai, Koichiro Yoneyama, Hiroki Yoshida, Keiji Nogami

    出版事項 2017
    全文の入手
    Artigo
    お気に入りに追加
    保存先:

検索ツール: